ABCELLERA BIOLOGICS INC's ticker is ABCL and the CUSIP is 00288U106. A total of 2 filers reported holding ABCELLERA BIOLOGICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $38,966 | -87.6% | 8,471 | -82.6% | 0.00% | -90.0% |
| Q2 2023 | $313,614 | +764812.2% | 48,547 | +801.2% | 0.01% | +900.0% |
| Q1 2023 | $41 | -71.3% | 5,387 | -61.9% | 0.00% | -83.3% |
| Q4 2022 | $143 | -99.9% | 14,139 | -9.9% | 0.01% | +100.0% |
| Q3 2022 | $155,000 | -7.2% | 15,690 | +0.1% | 0.00% | -25.0% |
| Q2 2022 | $167,000 | +1013.3% | 15,680 | +907.1% | 0.00% | – |
| Q1 2022 | $15,000 | +25.0% | 1,557 | +94.1% | 0.00% | – |
| Q4 2021 | $12,000 | -60.0% | 802 | -46.0% | 0.00% | -100.0% |
| Q3 2021 | $30,000 | +2900.0% | 1,484 | +2082.4% | 0.00% | – |
| Q2 2021 | $1,000 | -99.2% | 68 | -98.0% | 0.00% | -100.0% |
| Q1 2021 | $118,000 | +742.9% | 3,464 | +878.5% | 0.00% | – |
| Q4 2020 | $14,000 | – | 354 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DCVC Bio GP, LLC | 29,411 | $313,000 | 100.00% |
| Founders Fund VII Management, LLC | 3,773,530 | $40,188,000 | 93.02% |
| Gruss & Co., LLC | 363,778 | $3,874,000 | 26.99% |
| Founders Fund Growth Management, LLC | 407,017 | $4,334,000 | 12.66% |
| GUARDIAN CAPITAL ADVISORS LP | 3,836,414 | $44,387,000 | 5.09% |
| HARVARD MANAGEMENT CO INC | 4,105,095 | $43,719,000 | 5.06% |
| Intellectus Partners, LLC | 1,089,755 | $11,606,000 | 3.99% |
| ArchPoint Investors | 630,326 | $6,713,000 | 2.66% |
| BRANDYWINE MANAGERS, LLC | 56,976 | $607,000 | 1.49% |
| Orbimed Advisors | 4,180,768 | $44,525,000 | 0.81% |